Crestline Management LP Invests $211,000 in Encompass Health Co. (NYSE:EHC)

Crestline Management LP acquired a new stake in shares of Encompass Health Co. (NYSE:EHC - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 2,284 shares of the company's stock, valued at approximately $211,000.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in EHC. Tidal Investments LLC lifted its stake in shares of Encompass Health by 5.7% in the third quarter. Tidal Investments LLC now owns 3,509 shares of the company's stock worth $339,000 after buying an additional 188 shares in the last quarter. Miracle Mile Advisors LLC lifted its stake in shares of Encompass Health by 3.0% in the fourth quarter. Miracle Mile Advisors LLC now owns 3,835 shares of the company's stock worth $354,000 after buying an additional 112 shares in the last quarter. Pallas Capital Advisors LLC purchased a new position in shares of Encompass Health in the fourth quarter worth about $237,000. Oak Thistle LLC purchased a new position in shares of Encompass Health in the fourth quarter worth about $2,099,000. Finally, Park Avenue Securities LLC lifted its stake in shares of Encompass Health by 44.7% in the fourth quarter. Park Avenue Securities LLC now owns 6,737 shares of the company's stock worth $622,000 after buying an additional 2,082 shares in the last quarter. 97.25% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Encompass Health

In related news, EVP John Patrick Darby sold 10,000 shares of Encompass Health stock in a transaction that occurred on Tuesday, April 29th. The shares were sold at an average price of $114.79, for a total value of $1,147,900.00. Following the completion of the transaction, the executive vice president now owns 79,710 shares in the company, valued at $9,149,910.90. The trade was a 11.15% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Elissa Joy Charbonneau sold 4,279 shares of Encompass Health stock in a transaction that occurred on Tuesday, May 6th. The stock was sold at an average price of $116.61, for a total transaction of $498,974.19. Following the completion of the transaction, the insider now owns 11,958 shares of the company's stock, valued at $1,394,422.38. This represents a 26.35% decrease in their position. The disclosure for this sale can be found here. Company insiders own 2.00% of the company's stock.

Encompass Health Trading Up 1.0%

Shares of EHC traded up $1.17 during trading on Friday, reaching $120.94. 904,433 shares of the company traded hands, compared to its average volume of 694,702. Encompass Health Co. has a twelve month low of $82.74 and a twelve month high of $121.28. The stock has a market cap of $12.19 billion, a PE ratio of 27.12, a price-to-earnings-growth ratio of 2.31 and a beta of 0.91. The stock has a 50-day simple moving average of $105.43 and a 200-day simple moving average of $100.74. The company has a quick ratio of 1.04, a current ratio of 1.05 and a debt-to-equity ratio of 0.84.

Encompass Health (NYSE:EHC - Get Free Report) last announced its quarterly earnings results on Thursday, April 24th. The company reported $1.37 earnings per share for the quarter, beating analysts' consensus estimates of $1.19 by $0.18. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. The business had revenue of $1.46 billion during the quarter, compared to analysts' expectations of $1.43 billion. During the same period last year, the business earned $1.12 earnings per share. The business's revenue for the quarter was up 10.6% on a year-over-year basis. On average, analysts anticipate that Encompass Health Co. will post 4.8 earnings per share for the current year.

Encompass Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 15th. Investors of record on Tuesday, July 1st will be issued a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.56%. The ex-dividend date of this dividend is Tuesday, July 1st. Encompass Health's dividend payout ratio (DPR) is currently 14.05%.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on the stock. Truist Financial reissued a "buy" rating and issued a $135.00 price target (up from $116.00) on shares of Encompass Health in a research note on Monday, April 28th. UBS Group raised their price target on shares of Encompass Health from $117.00 to $130.00 and gave the stock a "buy" rating in a research note on Monday, April 28th. KeyCorp raised their price objective on shares of Encompass Health from $120.00 to $122.00 and gave the stock an "overweight" rating in a research report on Friday, April 25th. William Blair restated an "outperform" rating on shares of Encompass Health in a research report on Friday, February 7th. Finally, Barclays raised their price objective on shares of Encompass Health from $118.00 to $129.00 and gave the stock an "overweight" rating in a research report on Friday, April 25th. Nine equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the stock has an average rating of "Buy" and a consensus price target of $120.86.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.